Hypercell Technologies Inc. — SEC Form D Filing

Hypercell Technologies Inc. filed an SEC Form D on October 14, 2026, reporting $2.96M raised in Biotechnology.

Form D filing details

Filing
SEC Form D
Filing date
October 14, 2026
Amount reported
$2.96M
Round stage
Seed, as a $3.0 million equity offering is the standard size for early-stage biotechnology commercialization and field validation.
Industry
Biotechnology
Website
https://hypercelltech.com

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Food and agriculture supply chains suffer from delayed pathogen detection and quality control processes that lead to costly contamination outbreaks and food waste.

Solution

Hypercell Technologies builds point-of-care biotechnology diagnostics to rapidly detect biological pathogens and manage safety across the food, beverage, and agriculture sectors.

Why now

Tightening food safety regulations and heightened supply chain vulnerability require real-time biological screening over traditional days-long offsite lab testing.

Source: SEC EDGAR Form D filing